VALIDATION OF THE CUTANEOUS LUPUS ERYTHEMATOSUS QUALITY OF LIFE (CLEQOL), A CLE-SPECIFIC PATIENT-REPORTED OUTCOME MEASURE

The University Of Texas Southwestern Medical Center

Investigators